A multicentre feasibility study evaluating stress ulcer prophylaxis using hospital-based registry data

Edward Litton, Glenn M Eastwood, Rinaldo Bellomo, Richard W Beasley, Michael John Bailey, Andrew Benjamin Forbes, David J Gattas, David V Pilcher, Steven A R Webb, Shay P McGuinness, Manoj K Saxena, Colin McArthur, Paul Jeffrey Young

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)

Abstract

It is unclear whether histamine-2 receptor blockers (H2RBs) or proton pump inhibitors (PPIs) are preferred for stress ulcer prophylaxis (SUP) in intensive care unit patients. Suitably powered comparative effectiveness trials are warranted. To establish the feasibility of collecting process-of-care and outcome data relevant to a proposed interventional trial of SUP using existing databases. A retrospective cohort study conducted in seven Australia and New Zealand tertiary ICUs, including all patients =18 years admitted between 1 January 2011 and 31 December 2012. Doses of dispensed PPIs and H2RBs, upper gastrointestinal bleeding events, upper respiratory tract colonisation with pathogenic bacteria, Clostridium difficile infections and inhospital mortality. All sites were able to contribute to the study and investigators reported that data were generally easy to obtain. A median dose/ICU of 477 g of PPIs (interquartile range [IQR], 430.5-865 g), and 408.5 g (IQR, 109-1630.2 g) of H2RBs, were dispensed over the 2 years of the study. The median proportion of patients/ICU with upper GI bleeding complicating admission was 1.4 (IQR, 0.3 -1.8 ). Colonisation of the respiratory tract with gram-negative bacteria occurred in a median of 7.1 of patients/ICU (IQR, 6.3 -14.1 ). Pseudomembranous colitis occurred in hospital in a median of 1.4 of patients (IQR, 0.9 -2 ) and inhospital mortality was 10.6 (95 CI, 9.5 - 11.7 ). It is feasible to use existing data sources to measure process-of-care and outcome data necessary for a registry-based interventional trial of SUP.v
Original languageEnglish
Pages (from-to)158 - 163
Number of pages6
JournalCritical Care and Resuscitation
Volume16
Issue number3
Publication statusPublished - 2014

Cite this

@article{a701f58dd1104dae919fd28a76227ee8,
title = "A multicentre feasibility study evaluating stress ulcer prophylaxis using hospital-based registry data",
abstract = "It is unclear whether histamine-2 receptor blockers (H2RBs) or proton pump inhibitors (PPIs) are preferred for stress ulcer prophylaxis (SUP) in intensive care unit patients. Suitably powered comparative effectiveness trials are warranted. To establish the feasibility of collecting process-of-care and outcome data relevant to a proposed interventional trial of SUP using existing databases. A retrospective cohort study conducted in seven Australia and New Zealand tertiary ICUs, including all patients =18 years admitted between 1 January 2011 and 31 December 2012. Doses of dispensed PPIs and H2RBs, upper gastrointestinal bleeding events, upper respiratory tract colonisation with pathogenic bacteria, Clostridium difficile infections and inhospital mortality. All sites were able to contribute to the study and investigators reported that data were generally easy to obtain. A median dose/ICU of 477 g of PPIs (interquartile range [IQR], 430.5-865 g), and 408.5 g (IQR, 109-1630.2 g) of H2RBs, were dispensed over the 2 years of the study. The median proportion of patients/ICU with upper GI bleeding complicating admission was 1.4 (IQR, 0.3 -1.8 ). Colonisation of the respiratory tract with gram-negative bacteria occurred in a median of 7.1 of patients/ICU (IQR, 6.3 -14.1 ). Pseudomembranous colitis occurred in hospital in a median of 1.4 of patients (IQR, 0.9 -2 ) and inhospital mortality was 10.6 (95 CI, 9.5 - 11.7 ). It is feasible to use existing data sources to measure process-of-care and outcome data necessary for a registry-based interventional trial of SUP.v",
author = "Edward Litton and Eastwood, {Glenn M} and Rinaldo Bellomo and Beasley, {Richard W} and Bailey, {Michael John} and Forbes, {Andrew Benjamin} and Gattas, {David J} and Pilcher, {David V} and Webb, {Steven A R} and McGuinness, {Shay P} and Saxena, {Manoj K} and Colin McArthur and Young, {Paul Jeffrey}",
year = "2014",
language = "English",
volume = "16",
pages = "158 -- 163",
journal = "Critical Care and Resuscitation",
issn = "1441-2772",
publisher = "Australasian Medical Publishing Co. Pty Ltd. (AMPCo)",
number = "3",

}

A multicentre feasibility study evaluating stress ulcer prophylaxis using hospital-based registry data. / Litton, Edward; Eastwood, Glenn M; Bellomo, Rinaldo; Beasley, Richard W; Bailey, Michael John; Forbes, Andrew Benjamin; Gattas, David J; Pilcher, David V; Webb, Steven A R; McGuinness, Shay P; Saxena, Manoj K; McArthur, Colin; Young, Paul Jeffrey.

In: Critical Care and Resuscitation, Vol. 16, No. 3, 2014, p. 158 - 163.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - A multicentre feasibility study evaluating stress ulcer prophylaxis using hospital-based registry data

AU - Litton, Edward

AU - Eastwood, Glenn M

AU - Bellomo, Rinaldo

AU - Beasley, Richard W

AU - Bailey, Michael John

AU - Forbes, Andrew Benjamin

AU - Gattas, David J

AU - Pilcher, David V

AU - Webb, Steven A R

AU - McGuinness, Shay P

AU - Saxena, Manoj K

AU - McArthur, Colin

AU - Young, Paul Jeffrey

PY - 2014

Y1 - 2014

N2 - It is unclear whether histamine-2 receptor blockers (H2RBs) or proton pump inhibitors (PPIs) are preferred for stress ulcer prophylaxis (SUP) in intensive care unit patients. Suitably powered comparative effectiveness trials are warranted. To establish the feasibility of collecting process-of-care and outcome data relevant to a proposed interventional trial of SUP using existing databases. A retrospective cohort study conducted in seven Australia and New Zealand tertiary ICUs, including all patients =18 years admitted between 1 January 2011 and 31 December 2012. Doses of dispensed PPIs and H2RBs, upper gastrointestinal bleeding events, upper respiratory tract colonisation with pathogenic bacteria, Clostridium difficile infections and inhospital mortality. All sites were able to contribute to the study and investigators reported that data were generally easy to obtain. A median dose/ICU of 477 g of PPIs (interquartile range [IQR], 430.5-865 g), and 408.5 g (IQR, 109-1630.2 g) of H2RBs, were dispensed over the 2 years of the study. The median proportion of patients/ICU with upper GI bleeding complicating admission was 1.4 (IQR, 0.3 -1.8 ). Colonisation of the respiratory tract with gram-negative bacteria occurred in a median of 7.1 of patients/ICU (IQR, 6.3 -14.1 ). Pseudomembranous colitis occurred in hospital in a median of 1.4 of patients (IQR, 0.9 -2 ) and inhospital mortality was 10.6 (95 CI, 9.5 - 11.7 ). It is feasible to use existing data sources to measure process-of-care and outcome data necessary for a registry-based interventional trial of SUP.v

AB - It is unclear whether histamine-2 receptor blockers (H2RBs) or proton pump inhibitors (PPIs) are preferred for stress ulcer prophylaxis (SUP) in intensive care unit patients. Suitably powered comparative effectiveness trials are warranted. To establish the feasibility of collecting process-of-care and outcome data relevant to a proposed interventional trial of SUP using existing databases. A retrospective cohort study conducted in seven Australia and New Zealand tertiary ICUs, including all patients =18 years admitted between 1 January 2011 and 31 December 2012. Doses of dispensed PPIs and H2RBs, upper gastrointestinal bleeding events, upper respiratory tract colonisation with pathogenic bacteria, Clostridium difficile infections and inhospital mortality. All sites were able to contribute to the study and investigators reported that data were generally easy to obtain. A median dose/ICU of 477 g of PPIs (interquartile range [IQR], 430.5-865 g), and 408.5 g (IQR, 109-1630.2 g) of H2RBs, were dispensed over the 2 years of the study. The median proportion of patients/ICU with upper GI bleeding complicating admission was 1.4 (IQR, 0.3 -1.8 ). Colonisation of the respiratory tract with gram-negative bacteria occurred in a median of 7.1 of patients/ICU (IQR, 6.3 -14.1 ). Pseudomembranous colitis occurred in hospital in a median of 1.4 of patients (IQR, 0.9 -2 ) and inhospital mortality was 10.6 (95 CI, 9.5 - 11.7 ). It is feasible to use existing data sources to measure process-of-care and outcome data necessary for a registry-based interventional trial of SUP.v

UR - http://search.informit.com.au.ezproxy.lib.monash.edu.au/fullText;dn=560657288793845;res=IELHEA

M3 - Article

VL - 16

SP - 158

EP - 163

JO - Critical Care and Resuscitation

JF - Critical Care and Resuscitation

SN - 1441-2772

IS - 3

ER -